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Abstract
Adipose-derived stem cells (ADSCs) have proven their efficiency in wound 
healing and skin regeneration in vitro and in vivo. They were reported to differenti-
ate into skin cell types and migrate to wounded sites to restore cell deficiencies and 
functions. Secretome of ADSCs is involved in the migration and proliferation of 
dermal fibroblasts (DFs) and keratinocytes where growth differentiation factor 
11 (GDF11) and transforming growth factor-β (TGF-β) are expected to play the 
principal role. Both factors are implicated in immune responses, skin cell differen-
tiation, proliferation and pigmentation, migration and secretion of the extracellular 
matrix proteins. Increasing evidence has pointed the fact that ADSCs are expected 
to cross-react with GDF11 to ensure DF and keratinocytes proliferation to reverse 
the aging process. Moreover, these factors share similar intracellular mechanisms 
pathways that are SMAD-dependent, and target different cellular mechanisms 
related to regeneration or rejuvenation. This intriguing balance between GDF11-
dependent aging and TGF-β-dependent regeneration still remains unclear and 
might be regulated in a spatio-temporal manner. Considering the clinical relevance 
of the mechanisms slowing or delaying the onset of age, we aimed to clarify the 
involvement of cell signaling pathways related to GDF11 and TGF-β in balancing 
cell rejuvenation and cell regeneration. Increasing the organ lifespan and function-
ality might be challenging issues.
Keywords: adipose-derived stem cells, skin, aging, regeneration, rejuvenation, 
wound healing, GDF11, TGF-β, SMAD pathways
1. Introduction
Skin covers the human body and acts as a protective barrier against external 
aggressions; it consists of three component layers: epidermis, dermis, and hypo-
dermis. Skin also has a pivotal role in thermoregulation, water retention, and 
cell regeneration. However, the skin remains the first exhibition of time passing 
characterized externally by skin winkles’ manifestations, loss of integrity elasticity 
and functionality. These processes vary between individuals but altogether reflect 
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cellular and molecular changes leading to progressive reduction in cell proliferation 
and regeneration as a result of increasing cell senescence and apoptosis [1].
A recent work has testified that adult multipotent stem cells are present in the 
dermal sheets and in the interfollicular dermis; they can also be derived from the 
pericytes [2]. They are expected to play a crucial role in regulating skin function 
and turnover. Furthermore, these cells were considered as mesenchymal stem cell 
(MSC)-like expressing the specific mesenchymal markers and differentiating into 
adipocyte, chondrocyte, osteoblast and myocyte [3]. These cells are identified 
within the subcutaneous adipose tissue as adipose-derived stem cells (ADSCs) and 
have been reported to differentiate into skin cells, thus ensuring skin regenera-
tion and maintaining homeostasis [4–6]. Several studies have shown the ability of 
ADSCs to act through cell-cell contact, but mostly by secreting a panel of cytokines 
and chemokines, being involved in different biological pathways including cell 
proliferation, differentiation, homing and migration, senescence, and apoptosis 
[7–11]. These mechanisms are implicated in the whole process of skin regeneration 
during wound healing.
ADSC-based therapy is very promising in treating damaged tissues and in 
completing full-thickness skin replacement. Some clinical applications benefit 
from its simple and abundant collection from adipose tissue. The capacity of these 
cells to proliferate and self-renew in vitro as well as in vitro added to their innate 
differentiation has targeted more scientific advancements in the field of regenera-
tive medicine. Their immunomodulatory effects also make them more suitable for 
use compared to their counterpart from bone marrow and umbilical cord blood 
[12]. These cells have been used for many investigations and are largely used for 
graft improvement in cosmetic remodeling to prevent fat necrosis [13–15]. ADSCs 
have presented a great ability to migrate and were recruited rapidly into wounded 
sites where the process of cell differentiation toward various skin cell components 
occurred. ADSCs have helped in cicatrization and regulating inflammation and the 
phases of wound healing [6]. These cells secrete growth factors in their extracellular 
vesicles [16–18] and produce different amounts of the extracellular matrix (ECM) 
proteins, thus promoting and accelerating skin regeneration in 3D raft cultures 
from adult expanded human skin [19, 20]. This suggested that these cells repre-
sent a rich source of factors necessary for accelerating wound healing and tissue 
regeneration.
Among the secreted growth factors, transforming growth factor-β (TGF-β) and 
growth differentiation factor 11 (GDF11) are highlighted and both are involved 
in biology of skin and different organs [5, 21, 22]. Both factors belong to the same 
superfamily of TGF-β and target similar skin cells including dermal fibroblast (DF), 
keratinocytes, melanocytes, and dermal microvascular endothelial cells [23–25]. 
Moreover, these factors activate the intracellular SMAD signaling pathways, thus 
targeting skin cell properties to repair wounded tissues. Consequently, TGF-β 
reduces wrinkles and photoaging signs [24, 26, 27]. On the other hand, GDF11 has 
received more attention with its ability to produce age-reversing effects [25, 28] and 
increase skin cell proliferation and functionality [23–25].
In the current research, many questions have been raised about the involvement 
of GDF11 in the inflammatory, proliferative, and remodeling phases of wound 
healing. Adding to the fact that TGF-β was secreted by utmost epithelial cells and 
participated extensively in this cascade, an interaction between GDF11 and TGF-β 
for sustainable skin biology and function has been suggested. Additionally, they 
share similar intracellular mechanisms involved in healing and aging. Cross-talking 
with the surrounding cells, mainly resident ADSCs, keratinocytes, DF, melano-
cytes, and macrophages, these factors might be activated, autoactivated, and/or 
mediate other cytokines and chemokines to attain and orchestrate even similar 
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mechanism pathways but taking advantage for skin repair and cell regeneration or 
cell rejuvenation through resident’s stem cell proliferation and differentiation.
When secreting TGF-β and GDF11, ADSCs underwent autoinduction by bind-
ing these factors to their transmembrane specific receptors ActIIBR and TGF-βR 
respectively and initiating the intracellular signal transduction cascade. However, 
circulating GDF11 has been reported to decrease with age [21, 29] and, in the same 
way, younger ADSCs and MSCs were found to be more proliferative, secrete more 
ECM proteins, and be more rejuvenating as compared to the aged ones [18]. On 
the other hand, positive effects on skin vasculature, skin integrity, density and 
strength, and wrinkles reduction have been reported when using recombinant 
GDF11 (rGDF11) [24] likely by cross-talk between DF, keratinocytes, ADSCs, and 
endothelial cells. Its beneficial involvement in skin microvasculature impaired dur-
ing aging is highly expected through proliferation and differentiation of progenitor 
endothelial cells [30]. Other reports suggested that TGF-β was more involved in 
skin repair and cell regeneration during normal biological process or after injury 
and is considered as a key tool in the regulation of wound healing by promoting 
angiogenesis, cell proliferation, and migration [31]. Through its immunoregulating 
capacity, TFG-β and GDF11 were also specifically implicated in skin inflammatory 
process during wound healing and skin aging or inflamm-aging by downregulating 
proinflammatory cytokine genes expression [32, 33].
However, the relationships between TGF-β and GDF11 are not fully understood. 
With regard to their secretion levels and the skin regeneration and youth during 
aging, an expected ratio of TFG-β/GDF11 might be considered and regulated in a 
spatio-temporal manner and balance the whole cellular and molecular mechanisms 
associated to regeneration or rejuvenation. These regulating aspects must draw 
more attention as an important potential target attaining antiaging processes during 
wound healing.
2. Skin: anatomy and physiology
Skin thickness varies between people and with age and ranges on average from 
0.05 to 2 mm. Skin is comprised of three layers: non-vascularized and stratified 
epidermis, underlying the dermis composed of a connective tissue and the sub-
cutaneous adipose tissue forming the hypodermis including the adnexal structure 
[34]. The epidermis is preceded by an organized structure the stratum corneum 
formed by as interdigitated dead cells called corneocytes disposed as bricks between 
multiple lipid bilayers holding the structure defined as “brick and mortar” [35] 
and represent the first barrier to external factor penetration. The viable layers 
of the epidermis are stratum lucidum, stratum granulosum, stratum spinosum, and 
stratum germinativum. Keratinocytes composing these layers undergo progressive 
differentiation from the basal stratum germinativum to the outermost layer. These 
self-renewal and differentiation processes are important for epidermal regenera-
tion and lead to generation of solid lipid-rich cornified layers [36]. Melanocytes 
are other cells present in the epidermis; they synthetize the melanin pigment being 
transferred to mature keratinocytes, providing principal skin protection against 
UV damages. Merkel cells, dendritic cells, adipocytes, and Langerhans cells are also 
present within the epidermis.
Fibroblasts are the principal cells constituting the dermis; they are mesenchymal 
and represent skin scaffolds where they support other epithelial cells and the epi-
dermis through their elongation and shaped form, but especially through secretion 
of fibrous and elastic components constituting the ECM responsible for cutaneous 
strength and elasticity [34]. ECM is composed of fibrous proteins and a ground 
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substance. Both these components are rearranged to provide a three-dimensional 
microenvironment where epithelial cells, stem cells, and the vascular network 
are closely related to collagen, elastin, and fibronectin fibers [37]. In human skin, 
collagen fibers, mostly type I, III, and V, are the dominant components in the ECM 
accounting for 75% of the dry skin weight and confer elasticity and strength. Type 
I collagen represents 80–90% of the total collagen and type III up to 8–12% while 
type V collagen represents the remaining minor proportion [38]. ECM not only 
provides a structural support for skin cells but also plays very critical role in regulat-
ing cell behavior in normal conditions and wound healing [39]. This regulation 
occurs through molecular signaling mediated by integrin cell surface, which orients 
cells toward proliferation, differentiation, migration, or apoptosis [40].
Additional skin components residing in the dermis and sometimes in the hypoder-
mis are immune cells represented by lymphocytes, macrophages, mast and dendritic 
cells. Adnexal structures are located in the dermis and hypodermis and include hair 
follicles, blood vessels, nerves, eccrine glands, sebaceous glands, and apocrine gland.
The hypodermis layer or subcutaneous layer is composed mostly by adipose tis-
sue containing adipocytes, stem cells (ADSCs), and blood and lymph vessels. This 
adipose tissue is the main actor in regulating skin homeostasis, thermoregulation, 
metabolism, immune responses, and immunomodulation through a wide range of 
cytokines and chemokines secreted. This secretory panel conditions the microenvi-
ronment of the surrounding ADSCs and consequently their secretome to modulate 
skin cell proliferation, differentiation, migration, melanin production, and to 
induce skin rejuvenation [41–43].
3. Skin aging
3.1 Mechanisms of skin aging
Skin aging dependent on age or photoaging represents actually a real challenge 
of the new ADSCs advancements. The apparent skin physiology and morphol-
ogy represent the first signal of cell aging. Skin aging is represented by epidermal 
atrophy, wrinkles appearance, reduction of dermal thickness, and ECM degrada-
tion; adnexal structures also decrease in their number and function. Decrease in 
the number of epithelial cells including DF, melanocytes, and Langerhans cells was 
reported as well. Their replicative ability decreases with age, leading to senescent 
and non-dividing cells.
The thickness of subcutaneous adipose tissue is also reduced, showing a decrease 
in mitotic activity and self-renewal of ADSCs and increase in senescence of the 
surrounding cells. ADSCs might behave differently according to the context of 
stimulation, but the mainly important factors that are relayed to cell proliferation, 
proinflammation, and angiogenesis altogether are involved in cell regeneration.
3.2 Physiological markers of skin aging
We believe now that aging is associated to many intrinsic signaling pathway 
related to epigenetic factors, some genetic predispositions, and extrinsic factors 
such as ultraviolet radiations, air and water pollution, resulting in the impairment 
of skin integrity and youth. One could consider that UV/infrared (IR) irradia-
tions might lead to more cell damage than intrinsic factors. Indeed, following IR 
irradiation, skin cells present different DNA damages. Also, wrinkles, elasticity 
loss, pigmentation dysfunction, or hyperkeratosis are the most common symptoms 
reflecting the visual extent of aging as a result of the progressive atrophy of the 
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dermis. These manifestations rely on the impairment of cell senescence, a multi-
factorial event leading to skin integrity loss. Collagen production decreases and its 
degradation increases, leading to a quantitative and structural change in collagen 
fibers, which impact the dermis structure [44–46].
In humans, GDF11 is connected to age-related diseases and its serum level is 
associated with the physiology of aging [47, 48]. Its circulating level has been associ-
ated with aging in many human organs [23, 49, 50]. This factor was found to be able 
to antagonize aging specifically [29] and its remarkable action against myocardial 
hypertrophy and inflammation has been largely reported [28, 51, 52].
During skin aging, keratinocytes, DF and although endothelial cells secrete 
ubiquitous endopeptidases able to degrade the ECM proteins and called matrix 
metalloproteinase (MMP). Degradation of collagen fibers occurs with the major 
protease present in human skin MMP-1 that degrades type I and III collagen, fol-
lowed by MMP-3 and MMP-9 [53]. The specific tissue inhibitors of metalloprotein-
ases (TIMPs) regulate MMP processes where their increase in levels during aging 
was not concomitant with that of TIMPs leading to intrinsic collagen deficiency 
and accelerated skin aging. Moreover, Patel et al. have suggested that the ratio 
of MMP/TIMPs could be considered as a biomarker of wound healing and aging 
[54]. In photoaging, elastic fiber disorganization and degradation were observed, 
mainly due to activation of MMP-2, MMP-3, MMP-9, MMP-12, and MMP-13 [45, 
55, 56]. UVA-treated fibroblasts presented a typical senescence phenotype including 
upregulation of α-SMA, MMP-1, and MMP-2 expression [25].
Behind the increase in MMP levels, another component generated in skin cells 
is represented by reactive oxygen species (ROS). When activating the mitogen-
activated protein kinase (MAPK) family, transcriptional factors such as activator 
protein 1 (AP-1) and nuclear factor-kB (NF-kB) induce upregulation of MMP 
in DF and keratinocytes [57–60]. In addition, when cells aged, dysfunctions of 
mitochondrial electron transport chains and a decrease in mitochondrial activity 
were reported leading to higher production of ROS [61, 62]. Accumulation of ROS 
induced oxidative damages of structural proteins and lipoproteins, thus favoring 
cell senescence. On the other hand, this senescence might also be induced by the 
decline in replicative capacity due to DNA damage, including DNA methylation, 
histone deacetylation, or to chromatine architecture change and to gene expression 
which compromise the intended cellular function. The increase in mitochondrial 
ROS generation was also correlated to the decrease in DF size and spreading 
observed during progressive ECM degradation and impaired DF attachment due 
probably to the involvement of MMP production [57, 63, 64].
ROS also regulated different biological mechanisms including generation of 
inflammatory responses. Indeed, aging is associated to an increased secretion of 
proinflammatory proteins such as interleukin-6 (IL-6) and matrix metalloprotein-
ase (MMP)-9, leading to immune changes. Prolonged release of ROS in skin might 
amplify the inflammatory injury and promote chronic inflammation [65].
Some transcription factors such as P63 (P53 related protein) and P16INK4a are 
reported as indicators of keratinocytes senescence. Indeed, expression of P16INK4a 
positive cells increased with chronological aging in human dermis and epidermis 
while P63 expression was reduced [66, 67].
4. Role of ADSCs in skin regeneration
During normal development, skin regeneration is performed by the resident 
ADSCs providing for cellular turnover during skin homeostasis and repair after 
injury [41]. The basal layer is the skin location where these active multipotent stem 
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cells are responsible for recruiting and sending mature differentiated cells (kerati-
nocytes) to the outer layer of epidermis. Through a hierarchic gradient, these stem 
cells induced the regeneration of epidermis layer by ensuring self-renewal and a 
continuous production of transient amplifying cells [68]. Epidermal cells including 
ADSCs and DF closely interact to maintain local microenvironment propitious for 
cell turnover, leading to skin regeneration. Adding to their tendency to differenti-
ate into keratinocytes, DF, and probably melanocytes, cross-talk of ADSCs and 
these cells is a part of normal skin function where ECM secretion leads to a physical 
environment critical for the maintenance of the stem cell niche [69].
Another proof of the interactions between fibroblasts and ADSCs has been pro-
vided by Hu et al. where skin fibroblasts cell line HS27 was found to activate ADSCs 
to differentiate into fibroblast-like cells highly expressing vimentin, HSP47, and 
desmin mRNA level [70]. The interactions of microvascular endothelial cells and 
ADSCs are also of great interest in skin cell regeneration and proliferation by provid-
ing IL-6, IL-8, monocyte chemoattractant protein-1 (MCP-1) and VEGF, leading to 
inflammation and angiogenesis regulation [71, 72]. In normal conditions, ADSCs are 
continuously activated by human serum and platelets to induce their proliferation 
and differentiation. While in wounded tissues, platelets induced stem cells to initiate 
the inflammatory phase by secreting platelet-derived growth factor (PDGF), IL-6 
and IL-8, which lead to migration of macrophages and neutrophils to the wounded 
site [73], and TGF-β inducing induction of monocytes to macrophages (Figure 1). 
Figure 1. 
Implication of adipose-derived stem cells in the different phases associated to wound healing and in the 
rejuvenation process. ADSCs act on fibroblasts, macrophages, and skin cells through their secreted growth 
factors. GDF11 and TGF-β are present in all the phases, amplify fibroblast, macrophage, and ADSC secretion, 
leading to immune response, cell proliferation, and angiogenesis. However, their interactions are more relevant 
during proliferation phases where GDF11 might induce TFG-β induction in a spatio-temporal manner in 
addition to boosting fibroblast proliferation, resulting in the production of skin cell presenting young profile. 
GDF11: growth differentiation factor, TGF-β: transforming growth factor, ECM: extracellular matrix, PDGF: 
platelets-derived growth factor, Il-1,6,8,10: interleukin-1, TNF-α: tumor necrosis factor-α, b-FGF: basic-
fibroblast growth factor, VEGF: vascular endothelial growth factor, CXCR-4: C motif chemokine receptor 4, 
SDF-1: stromal derived factor-1, TLR2, 4: toll-like receptor2,4, GM-CSF: granulocyte monocyte-colony 
stimulating factor, IGF: insulin growth factor, MMP-1,-2, -9: matrix metalloproteinase-1, -2, -9, α-SMA: 
α-smooth muscle actin.
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Similar to platelets, ADSCs additionally secrete prostaglandin E2 (PGE2), TNF-α, 
and GDF11, thus potentiating proinflammatory responses and later anti-inflamma-
tory cytokine secretion by polarizing macrophages from M1 to M2.
In addition to TGF-β and GDF11, ADSCs secrete other growth factors such 
as basic-fibroblast Growth Factor (b-FGF), stromal-derived factor-1 (SDF-1), 
insulin-like growth factor (IGF), hepatocyte growth factor (HGF), and wingless 
10b (Wnt10b), which are involved in the mechanisms regulating skin cell regenera-
tion and repair [10, 23, 74]. The factors VEGF, PDGF, TGF-β, b-FGF, and HGF 
induce the formation of new blood vessels during the proliferative phase, probably 
through their differentiation into endothelial progenitor cells [10, 75]. The secreted 
GM-CSF can take part in this activation by inducing differentiation into committed 
monocytes potentially activated to macrophages and endothelial cells. In chronic 
radiation wounds, the use of ADSCs promoted new blood vessels damaged by 
the irradiation and increased the capillary density. These cells were found to act 
through stimulation of fibroblast proliferation and increase in VEGF secretion 
level [76].
However, endothelial cells and macrophages migration have been possible 
once after macrophages leaded to secretion of the ECM proteins especially col-
lagen I and III, elastin and fibronectin and to activation of DF to proliferate and 
migrate. DF also secretes VEGF, TGF-β, and b-FGF, leading to angiogenesis [75, 
77]. ADSCs are expected to participate actively in ECM production, whereby 
its abundant accumulation would facilitate cell migration and angiogenesis by 
autoinduction and amplification of the growth factor secretion implied. When 
miming injured conditions in vitro, ADSCs were indeed demonstrated to acceler-
ate neovascularization through the expression of hypoxia-inducible factor-1α [78] 
by regulating VEGF gene expression in endothelial cells [79]. These observations 
were confirmed in vitro in addition to an activation of stem cell proliferation 
and to keratinocytes chemoattraction and migration [80] likely facilitated by 
MMPs [81].
Migration of ADSCs to the injured site is of pivotal interest; their immune 
profile and their potential shift toward a more anti-inflammatory phenotype is 
required for the proliferation and remodeling phases of healing [82–84]. The cyto-
kine profile of T, B, and dendritic cells was influenced by ADSCs, which lead to the 
interruption of the inflammatory phase and starting the proliferation and remodel-
ing phases in chronic wounds [6, 85, 86]. The potential involvement of GDF11 in 
disrupting the proinflammatory status toward the anti-inflammatory one is likely 
due to its highly stimulation of DF and ADSCs and also by amplifying the action 
of TGF-β on ADSCs proliferation and secretome. This epigenetic modification and 
regulation of ADSCs’ microenvironment might be crucial in restoring cellular age 
defects and/or increasing cells’ ability to differentiate and migrate. The impact of 
changing microenvironment on induction of cell proliferation, differentiation, and 
migration has already been reported [41–43].
The collagen production amplified by cross-talk between ADSCs, DF, and 
TGF-β would facilitate the remodeling phase through inhibiting ECM degradation 
by increasing TIMPs’ secretion and their binding to MMPs [87]. Xiao et al. have 
reported that adipose tissue secretome increased N-cadherin and CD44 adhesion 
molecules involved in fibroblasts’ motility during wound healing and stimulation 
of fibronectin expression during ECM remodeling [88]. Combination of activin B 
and ADSCs led to rapid wound closure and to accelerated epithelialization through 
promoting keratinocytes and fibroblasts proliferation [5]. The integrin αβ6 exclu-
sively expressed by epithelial cells was associated to the regeneration of basement 
membrane zone during wound repair [89].
Figure 1 summarizes ADSCs’ mechanisms involved in tissue repair.
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5. ADSCs’ interactions with TFG-β and GDF11 for skin regeneration
Increasing evidence has implicated ADSCs in maintaining skin homeostasis at a 
cellular level through cell differentiation and at the paracrine level. The exosomes 
they secrete respond to the hemostasis of skin microenvironment by releasing the 
growth factors promoting neo-angiogenesis, cell differentiation, cell proliferation, 
and migration [11, 16, 90–92].
5.1 Proliferation and differentiation of ADSCs into skin cells
Through their secreting growth factors, ADSCs impacted cell proliferation, 
migration, and senescence, which are the physiological parameters associated with 
wound injury and aging. During wound healing, ADSCs and DF have been reported 
to optimize and address their local environment, the secreted ECM proteins have 
been reported to modulate the activity of keratinocytes and DF through mediating 
secretion of growth factors such as TGF-β to activate the healing process [41–43, 
69]. TGF-β plays a critical role in ECM protein production and especially collagen 
synthesis and degradation via the SMAD pathway [44]. Sasaki et al. were the first to 
identify the implication of MSCs in skin regeneration by their ability to differentiate 
and to repopulate damaged tissues [93]. Also, green fluorescent protein (GFP)-
positive bone marrow MSCs were able to differentiate into keratinocytes, endothe-
lial cells, and pericytes presenting altogether specific cell line markers [42].
Nevertheless, other factors are secreted by ADSCs or other epithelial cells that 
were recently identified to pave the way to the ones reported above or even have 
a place of honor in favoring skin regeneration or rejuvenation. In regard to this 
fact, the first on the list might be the GDF11, another member of the TGF-β fam-
ily recently involved in the structural and functional amelioration of skin cell and 
supporting skin stem cell proliferation and differentiation [23, 24].
GDF11, also known as bone morphogenetic protein-11 (BMP-11), is a disulfide-
linked dimer existing in a proactive form maturing after cleavage by furin-like 
proteases with 407 amino acids. This factor is expressed in embryonic tissues while 
mRNA and protein levels were differently appreciated with higher protein levels 
in soft tissue, cerebral cortex, adrenal gland, testis, and hippocampus [5]. Many 
physiological and pathophysiological functions are attributed to this factor, includ-
ing cell embryonic development, erythropoiesis, proliferation and differentiation, 
cardiovascular diseases, diabetes mellitus, and age-related diseases [5, 94].
However, the mostly important fact reported is that secreting GDF11 by ADSC 
originates the mechanisms related to cell differentiation and proliferation and cell 
migration even by upregulating genes involved in skin barrier function, in cellular 
proliferation, to epidermal turnover and differentiation and via modulating the 
TGF-β/SMAD pathway. Genes related to ECM production were also found upregu-
lated after Smad2 and Smad3 activation, in parallel to decrease in IL-1β proinflam-
matory cytokine-related gene [24]. Indeed, DF produced TGF-β and GDF11  
[95, 96] in addition to laminin, collagen, elastin, and fibronectin to ensure mechan-
ical stability of the dermis and participated to epidermis cell functions including 
those of keratinocytes and melanocytes. ADSCs were also reported to secrete ECM 
proteins participating in this activation loop.
Additionally, ADSCs might be automodulated by the secreted GDF11. On the 
other hand, GDF11 increased MMP-9 gene expression, which is known to interact 
with TGF-β to help wound closure and facilitate wound healing. However, high 
production of this protein is expected to improve matrix remodeling after injury 
rather than its degradation [97].
9Adipose-Derived Stem Cells (ADSCs) and Growth Differentiation Factor 11 (GDF11)…
DOI: http://dx.doi.org/10.5772/intechopen.91233
5.2 Skin cell migration
Subcutaneous MSCs mainly identified as ADSCs were considered as the prin-
cipal actor in the process of skin cell migration [93] but their presence within skin 
layers has not been established yet. Additionally, adipose tissue extract containing 
evidently ADSC’s secretome was able to significantly stimulate DF migration [25].
By expressing the chemokine receptor CCR7, which is the specific receptor of 
SLC/CCL21 involved in cell migration, MSCs accelerated their recruitment and 
migrated to the injured site, thus stimulating wound repair by giving rise to differ-
entiated skin cells in vivo.
TGF-β is secreted by DF, macrophages, and ADSCs and consequently amplifies 
angiogenesis and migration of ADSCs, keratinocytes, and DF by stimulating the 
SMAD2/3 pathway and increasing the expression of CXCR-4 receptor of SDF-1. 
This migration has been confirmed in vitro while ADSCs were recruited into 
damaged sites by SDF-1 [98], using the SDF-1/CXCR-4 axis and the intracellular 
Jak/AKt regulation pathway [99]. GDF11 also stimulated DF and keratinocytes 
to migrate into wounded sites [23]. By activating the same SMAD2/3/pathway, 
GDF11 and TGF-β stimulate skin endothelial cells to migrate, thus improving 
angiogenesis. This suggested that GDF11 activates the identical pathway in other 
skin cells such as DF and keratinocytes to improve cell migration and wound 
repair [24].
Other mechanisms leading to ADSC migration were reported after their activa-
tion by activin B, JRK, and ERK signaling appeared to be responsible for actin 
stress fiber formation involved in cell migration [5]. Interestingly, activin B was 
found to promote ADSC migration by enhancing α-SMA expression and stress fiber 
formation.
5.3 Melanocytes regulation
ADSCs also interplay with the activation loop of melanocytes by modulating 
enzyme-producing melanin activity. ADSCs by increasing their TGF-β secretion 
induced melanocytes to downregulate the expression of melanogenic enzymes and 
prevent site-specific pigmentation in reconstructed skin grafts. These interactions 
might be of interest in clinical applications by modulating melanin synthesis and 
impacting whitening of the skin through TGF-β [100]. DF increased TGF-β secre-
tion, thus maintaining melanocytes in an immature state, and acted on melanocytes 
to modulate melanin-producing enzymes and thus skin pigmentation [101], sug-
gesting that dermal composition in cells might determine the production of mature 
melanocytes and hence melanin transfer to keratinocytes. However, a recent study 
has shown that rGDF11 significantly reduced melanin production in melanocytes 
and 3D skin equivalents [24]. On the other hand, during aging, ROS accumulation 
by cell proliferation was reported as the initiator of the occurrence of vitiligo and its 
progression [102].
These reports might increase our thought on a potential ratio of GDF11 and 
TGF-β in different skin type and color. This ratio could result on a balance between 
skin pigmentation and skin yought and lead to a sustainable skin biology and 
function through regulation of the mechanisms related to skin cell proliferation and 
rejuvenation. If this is the case, one should conclude that white skins should present 
higher amounts of GDF11 and youthful aspects and present less symptoms of cell 
apoptosis and senescence during cell life. These observations must draw more 
attention in the future to better understand the paradigms triggering the mecha-
nisms related to skin aging and pigmentation.
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6.  TGF-β and GDF11 impacts on immunoregulatory effects  
of ADSC in skin
Evidence of involvement of ADSCs in immunomodulation of tissues and their 
presence within the epidermal layer have suggested that these cells might play 
a crucial role in skin immunological functions in physiologic and injured skin. 
Accumulation of senescent cells is related to the production of proinflammatory 
factors such as IL-6, IL-8, and TNF-α; we can postulate that the associated chronic 
inflammation is a promoting age-associated disease due to tissue aging. This skin 
inflamm-aging was also supported by highly secreted proinflammatory cytokine 
IL-1 β [32, 33]. Microvascular endothelial cells also interact with ADSCs to increase 
secretion of IL-6, IL-8, and MCP-1 to modulate skin inflammation [72].
TFG-β, secreted by ADSCs and other epithelial cells, is involved in the 
inflammatory, proliferative, and remodeling phases of wound healing. This fac-
tor activates M2 macrophages and secretion of ECM proteins involved in skin 
structure repair, in angiogenesis, in DF proliferation and cell migration, and 
re-epithelialization.
The integrin αβ6 secreted by epithelial cells was reported to activate TGF-β 
modulation and thus the innate immune surveillance in skin [89]. Recently, the 
collagen triple helix repeat containing one protein was reported to contribute to 
healing process via increasing M2 macrophages recruitment and TGF-β expression 
level [103].
In the same way, IL-6, the major proinflammatory component of ADSC’s 
secretome, was reported to initiate the inflammatory phase in injured tissues. 
Autoactivated ADSCs amplify their secretion and stimulate the secretion of TNF-α, 
TLR2, TLR4, IL-10, b-FGF, VEGF, TGF-β, and GDF11. These secretions would 
take place to short and shift the ADSCs profile to an anti-inflammatory profile and 
enhance angiogenesis, cell migration, and proliferation (Figure 2). Like TGF-β, 
Figure 2. 
Immunomodulatory effects of ADSCs. Through their secretome, these cells change the macrophages’ 
polarization and acquire an anti-inflammatory profile to enhance skin cell proliferation and migration and 
accelerate angiogenesis.
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GDF11 was found to be associated to the skin inflammatory status in both physi-
ological process and injury and participate in the regulation of the immune 
response.
To determine the effect of GDF11 on skin inflammation, a recent work of Wang 
et al. has shown that skin treatment with rGDF11 decreased the secretion of inflam-
matory cytokines by immune cells in vitro and in vivo in mice models of psoriasis-
associated inflammation, an extended infiltration of immune cells sustaining skin 
inflammation. Suppression of the severity of this inflammation by GDF11 was 
achieved by reducing macrophages infiltration to the skin and inhibiting the NF-kB 
signaling pathway [51]. Moreover, macrophages activation has been reported in 
skin autoimmune inflammatory diseases [104]. Other evidences argued on the 
protective effect of GDF11 from inflammatory reaction by inhibiting inflammatory 
responses in RAW264.7 macrophages [105], probably by inhibiting TNF-α release 
[106]. Additionally, TNF-α was activated by NF-kB signaling pathway during 
inflammation reaction, being suppressed by GDF11 in atherosclerosis. By reducing 
the NF-kB pathway, GDF11 also protected against apoptosis [105]. This suggested 
that the anti-inflammatory effect of GDF11 could open the way to potential new 
strategies for treating skin inflammations.
7. Antiaging mechanisms of ADSC within TFG-β and GDF11
7.1 Cellular implication
The mechanisms inducing tissue degeneration and cell aging remain multifacto-
rial and still unclear. Senescent ADSCs were likely found to be impacted in their 
ability to sustain tissue hemostasis and hence resulted in loss of tissue and organ 
integrity. Even these cells display a rich secretory profile; their ability to secrete 
ECM proteins, cytokines, and chemokines was largely impaired in vitro during 
culture expansion [107].
A recent clinical study has demonstrated that secretome of adipose tissue 
lipoaspirate extracellular fraction stimulates epidermal and dermal cell prolifera-
tion in a dose-dependent manner. This secretome has also the ability to delay 
apoptosis, enhance fibroblasts proliferation and migration, and reverse specifically 
the aging process and the associated skin symptoms [25, 28]. Exposure of fibro-
blasts to UVA was followed by preventing the upregulation of MMP1, MMP2, and 
α-SMA expression as well as lower elastin and collagen production associated to 
the senescence-like phenotype [25]. Indeed, ADSCs have proven their superiority 
in improving and increasing dermal thickness and reducing wrinkles more likely 
by inducing paracrine DF and angiogenesis [17, 18, 108]. Administrated intrader-
mally to an aged skin, skin texture and wrinkles as well as dermal thickness were 
found improved 8 weeks after treatment [74]. The extracellular vesicles released 
in ADSCs’ secretome or conditioned media enable the targeted cells to increase 
the production and deposition of ECM proteins including collagen and elastin [11, 
16, 90, 109, 110]. Among these autocrine/paracrine factors, TGF-β and GDF11 
appeared to be strongly associated (Figure 1).
Indeed, ADSCs-conditioned media in vitro and in vivo have proven their effi-
ciency in stimulating rejuvenation of human skin by improving skin elasticity and 
reducing wrinkles in a GDF11-dependent manner [111–113]. Their extract acted 
in a similar manner by activating DF and keratinocytes to proliferate and migrate 
into damaged sites [114]. An anti-wrinkle effect and dermal density increase were 
shown after in vivo treatment [23]. Moreover, the young cells secreting more GDF11 
supported higher proliferation rate of keratinocyte stem cells than those from aged 
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donors [115]. In the same manner, using platelets-rich plasma (PRP) for anti-wrin-
kle and anti-aging skin aspects appeared legitime related to its higher quantities of 
GDF11 [116]. Interestingly, GDF11 expression and activity were reduced in adult 
DF compared to the neonatal ones [95].
Fibroblasts were also recognized to play a crucial role in skin regeneration 
through GDF11 secretion in both neonatal and adult cells [95]. MSCs derived from 
placenta and umbilical cord blood promote fibroblasts plasticity [117] probably 
through GDF11 release, thus stimulating the rejuvenation of human skin [118]. 
These authors have effectively demonstrated that GDF11 activated fibroblasts to 
increase ECM proteins’ production and especially collagen I and III and fibronectin 
[23]. Also, MSCs have proven their proliferative superiority in young donors rather 
than the elderly [18].
In an animal model, transplanted autologous ADSCs improved skin-graft 
survival through secreting factors presenting anti-apoptotic activity [119]. In 
addition to ADSC, DF also appeared attractive in terms of protein secretion [109]. 
ADSC-conditioned media were anti-apoptotic and ensured skin tissue regeneration 
[119]; their protective and antiaging properties have been demonstrated on DF by 
preventing their oxidative stress and increasing their superoxide dismutase and 
glutathione peroxidase activities [120]. These cells act through their different and 
directed secretome to improve and induce tissue repair, consolidating their place as 
better candidate for regenerative medicine and opening recently the way for a new 
cell-free therapy [109, 121].
Moreover, by increasing collagenase matrix metalloproteinase-9 (MMP-9) 
secretion, rGDF11 participated in matrix remodeling maybe through interaction 
of MMP-9 with TGF-β1 to facilitate skin wound closure [97, 122]. These cell inter-
actions reveal the role of the TFG-β and GDF11 mechanisms used by ADSCs to 
interfere with the aging process [24, 95, 101].
7.2  Intracellular mechanisms pathway balancing between TGF-β  
and GDF11 in skin aging
Aging of ADSCs and DF was associated to upregulation of apoptotic genes 
and, consequently, the number of senescent cells increased [123]. However, recent 
studies have demonstrated that this senescence can be induced by TGF-β/SMAD as 
a normal developmental process [124]. Also, in aged skin, accumulation of senes-
cent cells and ROS likely impaired TGF-B pathway at least in DF.  The mechanisms’ 
pathways SMAD and Sirtuins are the mostly reported pathways whereby TGF-β and 
GDF11 acted.
The sirtuins are a family engaged in metabolism regulation and in aging-associ-
ated diseases, in addition to the mechanistic target of rapamycin (mTOR) signaling 
[16, 62, 125]. SIRT1 upregulation was reported to delay fibroblast’s senescence 
and its expression is significantly reduced in aged skin [126]. Additionally, SIRT1, 
SIRT3, SIRT5, SIRT2, SIRT6, and SIRT7 are involved in the regulation of oxidative 
stress and ROS production [127, 128]. Moreover, SIRT6 is implicated in the relation 
of DNA repair proteins to chromatin [129].
In wound healing, phosphorylation of TGF-β/Smad2/3 intracellular pathways was 
increased and resulted in protein transfer to skin cell [16, 130, 131], in DF proliferation 
and ADSCs differentiation into fibroblasts [70], and in improvement of angiogenesis 
[24]. Interestingly, aging and cell differentiation have been reversed by inhibiting this 
pathway [132]. Indeed, activation of SMAD2/3-dependent-TGF-β signaling inhibits 
adipogenic and osteogenic MSCs’ differentiation in vitro and in vivo [133, 134].
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ADSCs self-renew is regulated by AKT signaling through targeting PDGFA and 
activating the PI3K/AKT2 axis is required for ADSCs proliferation and maintenance 
in the dermis [135]. Hypoxic conditions might play a pivotal role in wound repair, 
and the same pathway has been found leading to the activation of PI3K/AKt signal-
ing [130]. In response to wound, ERK, AKt, and STAT-3 mechanisms pathways were 
activated and associated to stem cell proliferation and keratinocyte migration [80]. 
Interestingly, wound healing was specifically associated to microRNA and protein 
transfer to skin cells through the TGF-β/SMAD2 pathway, TGF-β being identified as 
a “mediator” [16, 132, 136].
TGF-β signaling pathway was recently reported as the main regulator of pluri-
potency [137]. Although epigenetically lacking myostatin is a highly homologous 
factor of GDF11, muscle multipotent stem cells can be reprogrammed to became 
pluripotent cells as embryonic cell-like. MicroRNA participates in this regulation 
probably by inhibiting TGF-β/Smad2 [132]. Epithelial differentiation was achieved 
by ADSCs through secreting Wnt10b and Wnt3a, a modulator of the Wnt/β-catenin 
implicated in replicative senescence regulation, suggesting that the regenerating 
and rejuvenating effect of GDF11 might also act via Wnt/β-catenin activation [138]. 
However, further investigations should be conducted to increase the knowledge on 
the intracellular mechanism used by the Wnt/β-catenin to delay the senescence of 
ADSCs and other targeted cells.
GDF11 is likely expected to act on other epidermal cells including DF, kerati-
nocytes, and melanocytes by regulating the genetic expressions of the different 
proteins involved in the antiaging process. Recombinant GDF11 was likely reported 
to reinforce human skin by highly increasing ECM genes expression related to 
ECM production such as COL1A1, COL6A6, CL14A1, ELN, TGFBR3, and HAS1. 
Skin barrier function was likely improved by enhancing expression of ALOX12, 
ALOX12B, ALOXE3, DSG1, and DSP genes. Genes related to epidermal cell pro-
liferation and differentiation were also upregulated in human skin through the 
Smad2/3mechanisms pathways [24].
Recently, fibroblast growth factors (FGFs) have been proposed as a therapeutic 
option to avoid skin aging aspects and to counter the cellular responses related to 
aging [139, 140]. Binding to tyrosine kinase receptors, they activate the autophos-
phorylation of Raf-1 belonging to the family of mitogen-activated protein kinase, 
kinase, kinase (MAPKKK), followed by that of MAPKK, which phosphorylates ERK 
(belonging to MAPK). Phosphorylation of these cyclin-dependent kinases in cell 
nucleus is involved in controlling cell division.
These FGFs are derived from fibroblasts and are decreased during their pro-
liferative and metabolic activities, thus reducing ECM proteins’ production. The 
decrease in FGF production also converge on the reduced amounts of collagen, 
decrease of dermal and epidermal integrity and elasticity and strength as signs of 
aging [141]. In addition to FGF secretion, fibroblasts are also targeted by TFG-β 
and GDF11 to activate the SMAD pathway leading them to have a pivotal role in 
skin regeneration. This suggests that FGF was expected to act independently but 
simultaneously to TGF-β and GDF11 to improve skin structure and aging aspects. 
Having a high mitogenic activity and high stability, rFGF-1 has been reported 
to strongly activate fibroblasts and keratinocytes proliferation with a potential 
use in angiogenesis, wound healing, and skin antiaging [142, 143]. In the same 
way, FGF-2 or b-FGF and keratinocyte growth factor (KGF) reduced wrinkles 
and increased proliferation of fibroblasts and keratinocytes modulating normal 
process of angiogenesis, tissue repair, and wound healing as well as significantly 
improving the antiaging process [27, 144, 145].
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8.  The spatio-temporal role of the TFG-β pathway in relationship  
with GDF11 in skin aging
When stimulating ADSCs through binding to their specific receptor mem-
brane, activin type IIB (ActIIBR), GDF11 activates the SMAD2/3 pathways. 
Similar mechanism might be achieved on ADSCs by TGF-β, suggesting that 
interference with TGF-β and GDF11 mechanisms might be the key regulator 
of healing and aging. The same activated SMAD mechanisms pathway did not 
achieve similar biological activity and targeted probably different intracellular 
and intranuclear effectors. These considerations might suggest that even different 
specific receptors are involved in the extracellular interactions of these factors, a 
competitive attractivity might be observed between their intracellular effectors, 
which are the SMAD 2/3 proteins. When the factors compete for these proteins, 
one can speculate that the favored pathway would be associated either to the 
amount of the activated receptor (TGF-β or GDF11) or to the sensibility of these 
receptors to their respective ligands.
Another point of view that could be important to mention is the variation in 
secretion level of these factors during aging. At this fact, serum level of GDF11 has 
been reported to decrease during age while TGF-β variation was not really investi-
gated. The antiaging pathway GDF11-dependent could be replaced progressively 
during aging by the TGF-β regenerating one. This might favor tissue regeneration 
and repair rather than rejuvenation, leading to the appearance of the symptoms  
of age.
Thus complicating the dilemma between rejuvenation and regeneration. 
Secretome composition of ADSCs might be impacted by the aging process or the 
different epigenetic factors.
9. Conclusion
In wound defects, ADSCs presented a great ability in migration and were 
recruited rapidly into wounded sites where the process of cell differentiation 
toward various skin cell components occurred. However, ADSCs participate 
more likely in all the phases of wound healing through autocrine and paracrine 
pathways [6]. Otherwise, during aging, senescent cells increase and the paracrine 
senescent secretome of ADSCs can trigger and reinforce senescence within their 
microenvironment [124]. This paracrine effect can be transmitted by ligands of 
TGF-β by mediating changes in the transcriptional program through SMAD family 
members [146].
Another surprising capacity of these cells is that secretome derived from 
younger cells is more suitable to increase proliferation than that derived from 
older cell [18], suggesting that younger cells have the potential to secrete a youth 
growth factor identified as GDF11, able to quantitatively increase cell proliferation 
at the younger stage. Targeted cells are the other crucial parameters leading to this 
increase; younger cells presented less senescence characteristics including DNA 
damage and ROS accumulation, thus, inducing cell rejuvenation. This process 
might be used to directly induce secretome of these cells toward tissue regeneration 
or rejuvenation.
We cannot exclude that MSCs and ADSCs secreted other cytokines than GDF11 
and TGF-β, such as PDGF, IL-1, bone morphogenic protein (BMP)6, BMP9, and 
exerted autocrine and paracrine effects on DF and keratinocytes, promoting 
cell differentiation, proliferation, and migration. Nevertheless, the antiaging 
paracrine effect seemed to be induced, perhaps not exclusively but at least to 
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a significant degree, by a combinatorial effect of both GDF11 and TGF-β. It is 
probable that both signals vary with age and that the strength of each of them is 
reciprocal to the sites of secreted signals and to the length of the exposure to the 
signal. Based on these considerations, further investigations on TGF-β and GDF11 
molecular mechanisms’ implication on skin rejuvenation are needed to increase 
our knowledge and draw conclusions on the regulation of aging process. Exciting 
therapeutic approaches might arise from the implication of GDF11 as an antiaging 
mechanism to increase the lifespan and the long-lasting functionality of different 
organs.
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